$KERX Headlines When it rains, it pours for Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2014 at 10:41 AM

$KERX Headlines

When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
Nasdaq extends break to less-charted territory 12:42 p.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 3:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 11:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 11:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 7:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 8:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 5:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 8:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 8:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 4:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 5:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 11:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 1:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 1:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 1:52 p.m. March 5, 2012 - Val Brickates Kennedy

Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains 8:00 a.m. Today - Seeking Alpha
Two new patents for Zerenex 9:55 a.m. June 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACOR SHPG WX ACT 6:45 a.m. June 18, 2014 - InvestorPlace.com
Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Conference (Transcript) 4:45 p.m. June 12, 2014 - Seeking Alpha
Building a Biotech Basket 5:00 p.m. June 11, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. June 4, 2014 - InvestorPlace.com
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation 7:34 p.m. May 29, 2014 - Seeking Alpha
Keryx PDUFA extension creates buying opportunity, Oppenheimer says 10:32 a.m. May 23, 2014 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's Pre-Market Mover With Heavy Volume Stock 9:02 a.m. May 23, 2014 - TheStreet.com
Keryx -4.9% AH; FDA extends goal date for Zerenex review 5:36 p.m. May 22, 2014 - Seeking Alpha
Keryx Ferric Citrate (Zerenex) Could Potentially Save Hemodialysis Patients $1B Annually 1:24 p.m. May 22, 2014 - Seeking Alpha
Seth Klarman's Baupost: Investment Changes During The First Quarter 11:40 a.m. May 19, 2014 - Seeking Alpha
Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, ... 5:20 p.m. May 15, 2014 - GuruFocus.com
Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update 4:18 a.m. May 15, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – HALO BKD ESC MCK 7:15 a.m. May 13, 2014 - InvestorPlace.com
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
My Favorite Investing Week 11:30 a.m. May 12, 2014 - RealMoney.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk 7:12 a.m. May 12, 2014 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 4:10 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)

Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference 4:30 p.m. June 17, 2014 - GlobeNewswire
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference 8:33 a.m. June 5, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
Annual Meetings, Clinical Data Presentation, Acquisitions, Agreements, and Date Extensions - Analyst Notes on Omnicare, Auxilium, Covance, Ophthotech and Keryx 7:30 a.m. May 27, 2014 - PR Newswire - PRF
Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM) 4:31 p.m. May 22, 2014 - GlobeNewswire
Upcoming Analyst Meetings, New Products, Collaborations, and Awards - Analyst Notes on Thermo Fisher Scientific, Agilent, United Therapeutics, Keryx and Centene 1:26 p.m. May 16, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results 7:01 a.m. May 8, 2014 - Thomson Reuters ONE
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces Opening of Boston Office 8:01 a.m. May 6, 2014 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results 4:40 p.m. May 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting 8:31 a.m. April 9, 2014 - GlobeNewswire
GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc. 8:31 a.m. April 9, 2014 - Thomson Reuters ONE
Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma 1:59 p.m. April 8, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 9:43 a.m. April 2, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 8:31 a.m. April 2, 2014 - Thomson Reuters ONE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quanta Services Reports Record Q3 2026 Earnings

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

2026 Data Integration Stars: User Sentiments Revealed

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Banco Macro S.A. Plans $160B Share Buyback Initiative

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Smartpress: Adobe & Canva Shape Print Design World

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Atlantic Blvd Apartments: A Game-Changer for Housing

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Clip Expands Horizons with Pulpos Acquisition, New Board Member

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Infection Control Market Set for Explosive Growth by 2031

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....